Medicare Enrolled
Dr. Hareesha Vemuganti, M.D
Internal Medicine · Cedar Park, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vemuganti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vemuganti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vemuganti
Dr. Hareesha Vemuganti is an internal medicine specialist in Cedar Park, TX, with 16 years of NPI registration. Based on federal Medicare data, Dr. Vemuganti performed 46,649 Medicare services across 1,648 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vemuganti received a total of $1,681 from 32 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vemuganti is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 1% volume in TX
$1,681 industry payments
Medicare Practice Summary
Medicare Utilization ↗46,649
Medicare services
Top 1% in TX for internal medicine
1,648
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,916 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
12,800 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 11,700 | $43 | $137 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
6,600 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
6,085 | $2 | $20 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
2,300 | $0 | $3 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,414 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
811 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
748 | $8 | $36 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
618 | $2 | $13 |
| Anti-nausea injection (Aloxi/palonosetron) | 600 | $1 | $114 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $91 | $368 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
216 | $22 | $157 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
207 | $96 | $707 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
177 | $9 | $56 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
139 | $55 | $250 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
113 | $14 | $73 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
111 | $15 | $76 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
105 | $4 | $23 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
100 | $48 | $313 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
98 | $6 | $431 |
| Immunoglobulin light chain measurement A blood test that measures the levels of immunoglobulin light chains, which are proteins produced by plasma cells. |
96 | $17 | $60 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
93 | $272 | $2,762 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
82 | $4 | $22 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
82 | $6 | $34 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 78 | $20 | $128 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
77 | $123 | $500 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
64 | $18 | $99 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
61 | $20 | $161 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
55 | $10 | $96 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
50 | $35 | $143 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
50 | $2 | $19 |
| Radiation therapy, 3+ areas, 11-19 MeV Delivery of high-energy radiation (11-19 MeV) to three or more separate treatment areas using custom blocking, tangential ports, wedges, rotational beams, and compensators. |
49 | $178 | $700 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
45 | $11 | $108 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
38 | $49 | $344 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
34 | $9 | $75 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
33 | $11 | $99 |
| Immunologic analysis of serum A laboratory test that uses immunologic techniques to analyze components in a blood serum sample. |
33 | $29 | $108 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
33 | $22 | $160 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $132 | $496 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
27 | $16 | $80 |
| New patient office visit, complex (60-74 min) | 23 | $158 | $709 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
20 | $16 | $100 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
19 | $40 | $821 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
19 | $23 | $256 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
16 | $145 | $1,067 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
13 | $114 | $565 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
91.5% medium
7.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,681
Total received (2021-2024)
Avg $420/year across 4 years
Top 32% in TX for internal medicine
32
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,251 (74.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$430 (25.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$904
2023
$461
2022
$286
2021
$30
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$299
Novartis Pharmaceuticals Corporation
$179
Karyopharm Therapeutics Inc.
$124
Lilly USA, LLC
$122
Medtronic, Inc.
$96
Apellis Pharmaceuticals, Inc.
$84
GlaxoSmithKline, LLC.
$84
Merck Sharp & Dohme LLC
$69
Janssen Biotech, Inc.
$52
GENZYME CORPORATION
$48
Seagen Inc.
$46
AstraZeneca Pharmaceuticals LP
$42
Celgene Corporation
$40
Gilead Sciences, Inc.
$33
TAIHO ONCOLOGY, INC.
$25
ABBVIE INC.
$25
E.R. Squibb & Sons, L.L.C.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$23
Eisai Inc.
$22
Mirati Therapeutics, Inc.
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
BeiGene USA, Inc.
$20
PFIZER INC.
$20
Secura Bio, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$19
Incyte Corporation
$19
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Jazz Pharmaceuticals Inc.
$18
Exelixis Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
EMD Serono, Inc.
$16
Amgen Inc.
$15
Top 3 companies account for 35.8% of total payments
Associated products mentioned in payments ›
ADAKVEO · BAVENCIO · CABOMETYX · COPIKTRA · DARZALEX · ENDO GIA ULTRA · Empaveli · Fabhalta · GILOTRIF · IBRANCE · IMFINZI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · OJJAARA · OPDUALAG · PADCEV · PREVYMIS · PROMACTA · Padcev · Pomalyst · SARCLISA · SCEMBLIX · Stivarga · TECVAYLI · TEVIMBRA · VENCLEXTA · VPRIV · Vyloy · XPOVIO · Xospata
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (74%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
880
Per 100K population
136.7
County median income
$108,309
Nearest hospital
CEDAR PARK REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vemuganti is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vemuganti experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Vemuganti performed 12,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vemuganti receive payments from pharmaceutical companies?
Yes. Dr. Vemuganti received a total of $1,681 from 32 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vemuganti's costs compare to other internal medicine physicians in Cedar Park?
Dr. Vemuganti's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vemuganti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Cedar Park
Browse internal medicine physicians in Cedar Park ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology